| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871159 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
We conclude that in human IMA, the third-generation dihydropyridine calcium channel antagonist benidipine has a potent inhibitory effect on the vasoconstriction mediated by a variety of vasoconstrictors. Use of benidipine in patients undergoing CABG may provide vasorelaxant or antispastic effects in the grafts.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hai-Tao BE, Jun BA, Zheng-Qing MD, Xiao-Cheng MD, Marija D. Pharm, Aleksandra PhD, Qin MD, PhD, Guo-Wei MD, DS,